Because sickle cell disease is a multisystemic disorder, it can result in a wide range of symptoms, explains columnist.

A student at Kennesaw State is helping develop a low-cost, light-based device to screen for stroke in children with sickle ...

With the Cell and Gene Therapy (CGT) Access Model, states will be reimbursed if cell and gene therapies don't benefit sickle cell patients.

Acute chest syndrome associated with sickle cell is driven by the abnormal activation of the complement cascade, per a study.

Intranasal fentanyl is a feasible, safe, and effective option for managing acute pain episodes in adults with sickle cell ...

Columnist Oluwatosin Adesoye, a doctor, sorts through the difference between sickle cell anemia and sickle cell disease — and ...

The gene-editing therapy OTQ923 normalized brain blood flow in 3 sickle cell disease patients, suggesting it may lower stroke risk, a study says.

Considering a change to your treatment regimen? Columnist Mary Shaniqua shares tips to help patients and providers make an informed decision.

Adults with sickle cell disease who are started on buprenorphine to ease chronic pain may be able to reduce their use of opioids, per a study.

Most people with SCD seem to meet or exceed current level of physical activity recommendations for the general population, a study shows.

BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 trial.